Please login to the form below
Ipsen
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.
Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities
by Ipsen. with support from Uptake Strategies Ltd. This industry-leading marketing excellence programme was designed and delivered within 8 weeks across 8 countries in a fully virtual way using interactive ... Boosting Ipsen’s Asia-Pacific Marketing
Resetting Customer Relationships
Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities. ... Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities - by Ipsen. with support from Uptake Strategies Ltd.
A Sporting Games Initiative to Boost Learner Engagement
Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities. ... Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities - by Ipsen. with support from Uptake Strategies Ltd.
Gecko – A Voyage of Discovery for Digital Learners
Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities. ... Boosting Ipsen’s Asia-Pacific Marketing Team’s Capabilities - by Ipsen. with support from Uptake Strategies Ltd.
European Commission approves Opdivo plus Cambometyx for advanced kidney cancer
The European Commission (EC) has approved a combination of Bristol Myers Squibb’s (BMS) Opdivo with Ipsen’s Cabometyx for the first-line treatment of advanced renal cell carcinoma (RCC) – the ... The EC approval for Opdivo plus tyrosine kinase
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- AstraZeneca's Enhertu receives FDA grant for priority review
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- GSK appoint Tony Wood as chief scientific officer
- Anthem PR appoints new managing director Rebecca Fergusson
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Developing Innovative Digital Strategies to Engage Patients
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
Latest intelligence
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
- Hybrid working: Insights and tips for success
- Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
